Latest Genmab News & Updates

See the latest news and media coverage for Genmab. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Genmab

Therapeutic antibody developer

genmab.com
Headquarters
2500 Valby, Denmark
Company type
Public company
Number of employees
2,500–5,000

Last updated

Latest news about Genmab

In short: Genmab completed major acquisitions, reported strong financial growth, and strategically refined its oncology pipeline to focus on patient impact.

Company announcements

  • Genmab

    Genmab announces Q1 2026 financial results

    Revenue increases 25% to $896 million driven by royalties and EPKINLY sales. FDA approves sBLA for DLBCL. Maintains 2026 guidance.

  • Genmab

    Genmab reports DARZALEX Q1 2026 net sales

    Worldwide net trade sales totaled USD 3,964 million, including USD 2,208 million in the U.S. and USD 1,756 million elsewhere; Genmab receives royalties from J&J.

  • Genmab

    Genmab names Margarida Duarte General Manager Europe and Emerging Markets

    She brings over 20 years of biotech leadership in oncology. She will oversee commercial operations across these markets from Zug, Switzerland.

  • Genmab

    Genmab corrects share price in announcement No. 13

    The price was erroneously reported as DKK 0.00; correct price is DKK 1,867.50 for transactions by managerial employees and associated persons.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Genmab

Track Genmab and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Genmab competitors & trending companies

Browse news for competitors to Genmab and other trending companies.